Mālama ʻia ka mea hana no ka mālama ʻana i nā maʻi maʻi type 2. Hoʻokomo ka mea hana i nā seleka pancreatic e hana hou i ka insulin e hoʻohaʻahaʻa i ke kō koko.
Inoa Kūʻai ʻole honua
Gliclazide.
Hoʻolālā ʻia ka Diabeton MV no ka mālama ʻana i nā maʻi maʻi type 2.
ATX
A10BB09.
E hoʻokuʻu i nā palapala a me ka ʻano
Loaʻa i ka palapala papa:
- 15 nā pcs., Hoʻopili i nā blisters no 2 a 4 mau pcs. me nā ʻōlelo no ka hoʻohana ʻana i hoʻopuni ʻia ma ka pahu kāpuni;
- 30 mau pcs., Nā kīwī like o 1 a i ʻole 2 mau blu pākahi.
Aia ka papa 1 i ka 60 mg o ka waiwai ikaika - gliclazide.
Nā mea kōkua
- hypromellose 100 cP;
- anomedrous colloidal silicon dioxide;
- maltodextrin;
- magnesium stearate;
- liʻawaʻawa lactose.
Loaʻa ka Diabeton MV i ka palapala papa.
Ka hana lāʻau lapaʻau
Hoʻopilikua ʻo hypoglycemic āpau.
ʻO ka mea hana e hana ai he sulfonylurea. Hoʻohālikelike ʻia me nā analogs, loaʻa ia i ka nitrogen me kahi kaula endocyclic i loko o ke apo heterocyclic. Ma muli o ka hana o ka gliclazide i loko o ke koko, e hoʻohaʻahaʻa ka hapa nui o ka glucose, a me ka huna ʻana o ka insulin i nā hua beta o nā mokupuni o Langerhans.
ʻO ka hoʻonui hoʻonui nui o ka C-peptide a me ka insulin postprandial e hoʻomau i nā makahiki 2 ma hope o ka mālama ʻana.
ʻO ka kōpaʻa o ka huka i loko o ka maʻi diabetes 2, i ka wā e lawe ai i ka lāʻau lapaʻau, kōkua i ka hoʻihoʻi ʻana i ka wana mua o ka mea huna o ka insulin a hoʻoikaika i kāna lua. Hoʻonui nui ka mea huna me ka hoʻokomo ʻana i ka glucose.
ʻO ka hoʻonui hoʻonui nui o ka C-peptide a me ka insulin postprandial e hoʻomau i nā makahiki 2 ma hope o ka mālama ʻana.
He hopena hemovascular. Hoʻopilikia ka mea ikaika i nā kaʻina hana i hiki ke hoʻopili i ka hoʻopiʻi ʻana i nā hoʻopiʻi i ka maʻi diabetes, e like me:
- ʻO ka hoʻohaʻahaʻa ʻana i ka pae o ka thromboxane B2 a me nā beta-thromboglobulin e hoohoihoi ana i nā platelets;
- ka hoʻopiha piha ʻana o ka pā adhesion a me ka hoʻohui ʻana o kēia mau mea i hoʻohālikelike ʻia.
Hoʻolālā ka hoʻonui ʻana i ka hana o ka plasminogen kiko hana a hoʻihoʻi hou i ka hana fibrinolytic o ka votone endothelium.
Lapaʻau lāʻau
ʻO ka hoʻopili piha ʻana o ka mea hana ikaika e kū mai ma hope o ke kau ʻana i ka lāʻau, me ka ʻole o ka komo ʻana o ka meaʻai. Loaʻa ka hoʻonuiʻana i ka neʻe o ka plasma i nā hola 6 mua. ʻO ka mālama ʻana i ka pae pākeke ke 6-12 hola. Ke hoʻomanawanui ʻole nei nā pilikino.
I ka 95% o ka waiwai hana e hoʻopili ai i nā protein plasma. ʻO ka nui o ka hoʻoilina he 30 lita. ʻO ka lawe ʻana i kahi papa 1 i kēlā me kēia lā ke mālama i ka kaona o ka gliclazide e pono ai i ke koko no ka ʻoi aku o ka lā.
ʻO ka Metabolism ka mea nui i ka pīpī.
ʻO ka Metabolism ka mea nui i ka pīpī. ʻAʻohe huahana metabolites ikaika i loko o ka plasma. ʻO nā Metabolites ke hoʻopiʻi ʻia ma ka maʻamau o nā keiki, ka liʻiliʻi o 1% - i loli ʻole. ʻO ka hoʻopau hapa hapalua-ola he 12-20 hola.
Nā hōʻailona no ka hoʻohana ʻana
Ke kuhikuhi ʻia nei ka lāʻau lapaʻau no ka hoʻoponopono waha ʻana i nā maʻi aʻe.
- i ka mua o ke ʻano maʻi mellitus type 2 me ka hana haʻahaʻa o ka meaʻai i hoʻopili ʻia, ka hana kino a me ke kaumaha;
- no ka pale ʻana i nā hoʻopiʻi: ka nānā ʻana o ka maʻi glycemic intensive o ke ʻano o nā mea maʻi e hōʻemi i ka hopena o ka micro- (retinopathy, nephropathy) a me nā hopena macrovascular (stroke, myocardial infarction).
Ua kuhikuhi ʻia aku nei ka maʻi Diabeton MV ma mua o ka maʻi mellitus type type 2 me ka hana haʻahaʻa o ka meaʻai kūpono, nā hana kino a me ke kaumaha.
Nā Hoʻohui
ʻAʻole kuhikuhi ʻia ka lāʻau lapaʻau i loko o nā hihia penei:
- hypersensitivity i gliclazide a me nā mea ʻē aʻe o ka lāʻau lapaʻau, e komo i nā sulfonamides;
- maʻi type type 1;
- lawe ʻana i ka miconazole;
- hapai a lactation;
- maʻi maʻamau precoma a me ka pōʻai ʻole;
- hōʻeha ʻole a he renal paha ʻole;
- maʻi ketoacidosis maʻi.
Hoʻopiʻi ka lāʻau i ka minors.
ʻAʻole ia no ke hoʻohana ʻana i nā maʻi ma nā maʻi me ka malabsorption glucose-galactose, galactosemia, congenital lactose intolerance.
Me ka mālama pono
Hoʻohana ʻia ka lāʻau lapaʻau no ka:
- waiʻona wai;
- pituitary a adrenal, renal a i ʻole poho;
- ka nele o ka glucose-6-phosphate dehydrogenase;
- pilikia ponoʻi cardiovascular;
- ka hoʻohana ʻana o ka glucocorticosteroids;
- ke kūleʻa ʻole ʻole a i ʻole nā hoʻoponopono ʻole;
- elemakule.
Pehea e lawe ai i ka Diabeton MV?
ʻO ka lā helu i kēlā me kēia lā he 0.5-2 papa 1 ka manawa i ka lā. Puka ʻia nā papa āpau me ka ʻole o ka uʻi a me ka nalo ʻana.
Puka ʻia nā papa āpau me ka ʻole o ka uʻi a me ka nalo ʻana.
Hōʻalo ʻia nā mea i hala ʻole ʻia no ka hoʻonui ʻia ʻana o ka hopena i loko o nā manaʻo i hōʻike ʻia aʻe.
Ua hoʻoholo ʻia ka lāʻau e ka kauka e kau i ka pae o HbA1c a me ka pae koko koko.
Hana no ka pale ʻana i ka maʻi maʻi
Hoʻomaka ka mālama ʻana me kahi papa ½. Inā mālama ʻia ka pono kūpono, a laila lawa kēia wai no ka mālama pono ʻana. Inā lawa ʻole ka mana glycemic, ke piʻi pinepine ʻia ka lāʻau i ka 30 mg ma hope o ka liʻiliʻi 1 mahina o ka lawe ʻana i ka lāʻau lapaʻau ma mua o ka hopena i kuhikuhi ʻia ma mua, me ka hoʻoliʻina ʻana o nā mea maʻi o nā glucose i hōʻemi ʻole ma hope o kahi papa hana no 2 pule. No nā mea i hala, hoʻonui ʻia ka maʻi ma mua o 14 mau lā ma hope o ka hoʻomaka ʻana o ka hoʻokele.
ʻO ka dosis kiʻekiʻe loa i kēlā me kēia lā he 120 mg.
Hoʻomaka ka mālama ʻana me kahi papa ½.
No nā mea maʻi i ka pilikia o ka hoʻomohala ʻana i ka hypoglycemia, kahi palena liʻiliʻi (0,5 papa) i kuhikuhi ʻia.
No ka paleʻana i nā hoʻopiʻi o ka maʻi maʻi, hoʻonui ʻia ka nui o ka lāʻau i ka 120 mg / lā. Ke lawe nei i ka lāʻau lapaʻau me ka hana pilikino a me ka meaʻai a hiki i ka pae kiʻekiʻe o ka HbA1c a hiki. I ka wā mālama, hiki ke hoʻohana ʻia nā lāʻau hypoglycemic ʻē aʻe:
- Insulin
- alpha glucosidase inhibitor;
- thiazolidinedione derivative;
- Metformin.
Ke lawe nei i ka lāʻau lapaʻau pū ʻia me ka meaʻai.
Hoʻohanaʻike kino
Pono ka bodybuilder i kahi papa insulin no ka loaʻa ʻana o ka paona wikiwiki. I kēia haʻuki, ua kaulana nō ma muli o ka:
- kūʻai wale aku i loko o nā hale kūʻai;
- ʻaʻole hoʻokomo i kahi pilikia olakino;
- i kona hopena ngawari i ke kino.
Pono e hoʻohui pū ʻia ka hoʻohana ʻana o ka lāʻau lapaʻau me ka ʻai kūpono o ka mea hoʻokūkū. ʻOi aku ka maikaʻi e kālua a pulu i ka pala. Lawe ʻia ka lāʻau ma luna o ka ʻōpū ʻole i hala i hoʻokahi hola ma mua o ka papaʻaina. Mai ʻai i ka meaʻai i ka wā e hoʻomaʻamaʻa ana a me ka 1 mau hola ma mua a ma hope iho.
Lawe ʻia ka lāʻau lapaʻau i nā manawa 3 i ka lā. Hoʻoholo ʻia ka ʻōpala e ka lehulehu o ka mea hoʻokūkū. Hoʻonui ʻia ke alakaʻi i ka overeating, tk. ʻO ka hoʻemi ʻana i ke kōʻai e koi ai i ka uku ʻana i ke ʻano o nā meaʻai kiʻekiʻe.
Pono ka bodybuilder i kahi papa insulin no ka loaʻa ʻana o ka paona wikiwiki.
Nā hopena hopena
Ke hoʻohana nei i ka gliclazide, e like me nā lāʻau lapaʻau sulfonylurea, hiki i ka lāʻau lapaʻau ke hōʻeha i ka hypoglycemia i ka wā e hemo ana i ka meaʻai a i ʻole nā hoʻoponopono. Nā mākaukau i ʻ :lelo ʻia:
- bradycardia;
- hui puʻu;
- manaʻo o ka hemahema;
- ka nalowale o ka ʻike me ka hoʻomohala ʻāua o ka coma me ka loaʻa ʻole o ka make;
- ʻʻAla
- nahoa
- luhi;
- nāwaliwali
- paresis;
- hāpau
- lilo ana o ke kāohi hoʻokele ponoʻī;
- paneʻike a me ka ʻōlelo;
- aphasia;
- Hōʻikeʻike
- ua hōʻemi ʻia ka nānā ʻana;
- pupule o ka ike;
- aūlū
- huhū;
- ninaki a me ka luaʻi
- hoʻomoe;
- māhuahua ka manaʻo o ka pōloli;
- lie kanikela.
Ua ʻike ʻia nā hopena Adrenergic:
- angina pectoris;
- arrhythmia;
- Kuhi kaumaha
- tachycardia;
- palpitations
- ke koko kiʻekiʻe;
- ʻiliʻili polū;
- hipogekisisis.
Ua hoʻokūpaʻa nā hoʻokolohua Laboratory hiki ke hoʻokō ʻia ka hana ʻokaʻā o ka ate me ka hoʻomohala ʻana o ka cholestasis.
ʻO nā hōʻailona o ka maʻi e kāpae i ka hoʻokomoʻana i nā aʻe. ʻO ka lawe ʻana i nā mea momona ʻaʻole pono. ʻAʻole ia e kauoha ʻia e lawe i nā mea waiwai o sulfonylurea.
ʻŌpala Gastrointestinal
No ka hōʻemi ʻana i kēia mau hopena ʻaoʻao, pono ʻoe e lawe i ka lāʻau lapaʻau i ka wā e ʻaina ana i ka ʻaina kakahiaka. E pili ana kēia:
- ninaki a me ka luaʻi
- constipation
- nā ninia
- ʻeha ka ʻōpū.
Hematopoietic mau hui
Loaʻa pinepine ʻia:
- granulocytopenia;
- leukopenia;
- thrombocytopenia
- anemia
Hoʻopili pinepine ʻia i ka hoʻokuʻu ʻana i ka lāʻau.
Hiki i ka Diabeton MB ke hōʻeha i ka ʻeha o ka ʻōpū.
Pūnaehana pīhoihoi waena
Nā mea penei:
- ka ʻike hemahema o ka ʻenehana;
- ʻeha kaumaha.
Mai ka pūnaehana urinary
ʻAʻohe e ʻike.
Ma ka ʻāpana o nā lālā o ka hihiʻo
Hiki i nā pilikia ke nānā aku me nā loli o ke kō koko koko. ʻO ka hapa nui o ka wā mua o ka mālama ʻana.
Inā hoʻololi ʻoe i kāu kō koko koko i ka wā e lawe ai i ka lāʻau lapaʻau, e piʻi ana kou maka maka.
Ma ka ʻāpana o ka ʻili
Nānā ʻia:
- Maʻiʻo Stevens-Johnson;
- erythema;
- ʻO ka makeʻe o Quincke;
- huu
- toxic epidermal necrolysis;
- rash, incl. makulopapullous;
- urticaria.
Ma ka ʻāpana o ka ate a me ka pāpaʻi biliary
Nā mea penei:
- hepatitis i nā hihia kaʻawale;
- ka hana nui o nā ʻōnaehana o nā ate (alkaline phosphatase. AST, ALT).
Hoʻōki ka mālama ʻana i ka wā e loaʻa mai ai nā jaundice cholestatic.
I nā hanana pinepine, hiki i ka maʻi hepatitis ke mālama ʻia me ka maʻi Diabeton MV.
Nā ʻōlelo kikoʻī
Hāʻawi ʻia ka lāʻau lapaʻau no nā mea maʻi e ʻai ʻai i nā meaʻai momona a me ke kakahiaka ʻaina. Hoʻonui ʻia ke ʻano o ka hypoglycemia e:
- hoonui holomua;
- ka lawe ʻana i kekahi mau lāʻau hypoglycemic i ka manawa like;
- haʻahaʻa kaloria meaʻai;
- mea inu waiʻona.
Ke kāpae nei i nā hōʻailona ke kāpae i ka hoʻomaha. Me nā hōʻailona koʻikoʻi, lawe pū ka mea maʻi i ka haukapila.
Hoʻopilikia ka pilikia o ka hypoglycemia me:
- overdose;
- pilikia a me ka hana hema ʻole;
- lawa adrenal a pituitary;
- maʻi maʻi thyroid;
- ke hoʻokaʻawaleʻana ma waena o ka nui o nā hāmeʻe i lawe ʻia a me ke ʻano kino;
- ka hoʻokaʻawale ʻana i kekahi o nā lāʻau e hoʻopili;
- ka hiki ʻole o ka mea maʻi ke kāohi i kona kūlana;
- ka hoʻololi ʻana i ka meaʻai, ke ʻoki ʻana i ka pāʻina, ka hoʻokē ʻai, nā ʻuna ʻole a me ka pono ʻole.
Hoʻonui ka hopena o ka hypoglycemia me ka maʻi thyroid.
Hoʻolaha ka waipuna
I ka wā e kauoha ʻia ai ka palaka ʻana me ka makaʻala. ʻO ka inu waiʻona e hoʻowalewale i ka glycemia.
Hoʻopilikia i ka hiki ke mālama i nā mīkini
Hoʻomaopopo ʻia nā mea maʻi i nā hōʻailona o ka hypoglycemia. E akahele lākou me ka wā e hana i nā hana e pono ai ke kiʻekiʻe a me ka wikiwiki o ka hopena psychomotor, ʻoiai ma nā hana mua o ka mālama ʻana.
Hoʻohana i ka wā hāpai a me ka lactation
ʻAʻole ʻike ka ʻike e pili ana i ka hoʻohana ʻana i ke ʻano o ka mea hana i ka wā hapai. I nā hoʻokolohua holoholona, ʻaʻohe ʻike ʻia ka hopena teratogenic.
Me kahi wahine i hoʻolālā ʻia a me kāna hoʻomaka ʻana i ka wā o ka maʻi maʻi, e hōʻike ʻia e hoʻololi i nā kūlohelohe waha e hoʻohālikelike ai i ka maʻi insulin.
Ma muli o ka hapa ʻole o ka ʻike e pili ana i ka komo ʻana o ka waiwai ikaika i ka umauma umauma, ka lawe ʻana i ka lāʻau lapaʻau i ka wā o ka hoʻoulu ʻana o ka maʻi a contraindicated.
ʻAʻole ʻike ka ʻike e pili ana i ka hoʻohana ʻana i ke ʻano o ka mea hana i ka wā hapai.
Koho ʻana i ka Diabeton MV i nā keiki
ʻAʻohe ʻikepili i ka hopena o ka lāʻau lapaʻau i nā keiki liʻiliʻi.
Hoʻohana i ka wā kahiko
ʻAʻole mālama ʻia nā hana nui o nā lāʻau lapaʻau i ka wā kahiko.
Ke noi no ka hana renal haukapole
Ma nā pilikia hoʻokalakupua nui, ʻōkuhi ʻia ka insulin. I nā haʻahaʻa a me ke kaulike o kēia heleʻana o ke ʻano, ʻaʻole i loli ʻia ka make.
Hoʻohana no ka hana lawelawe lēwa
Contraindicated ma ka palaualole maikaʻi ʻole.
Ma nā pilikia hoʻokalakupua nui, ʻōkuhi ʻia ka insulin.
Ke keu
Inā nui ae ke ʻano nui, e ulu paha ka hypoglycemia. Inā hele mai nā ʻōhua kūpono o kēia maʻi me ka ʻike ʻole o ka neurological a me ka ʻike ʻole ʻole, e hoʻonui i ka nui o nā meaʻai o ke kāʻei i kaʻai, hoʻololi i kaʻai a / a hōʻemi i ka wī.
ʻO nā hiʻohiʻona koʻikoʻi o nā kūlana hypoclycemic, hōʻike ʻia e nā ʻano like ʻole o ka neurological, a me nā na mea koikoi a me kahi coma, e koi koke i ka halihali koke.
Inā kānalua ka hypoglycemic coma a i kona hoʻomaka ʻana, kahi hopena o ka glucose 20-30% i loko o kahi nui o 50 ml e lawelawe ʻia i ka mea maʻi intravenously. No ka mālama i nā pae koko koko ma luna o 1 g / l, e mālama ʻia kahi hopena o ka dextrose 10%. No nā hola 48, ke nānā ʻia nei ke kūlana o ka mea maʻi, a ma hope o ka manawa e hoʻoholo ai ke kauka i ka pono no ka nānā hou aku.
ʻAʻole kūleʻa ka Dialysis, no ka mea ke pili pū ka mea ikaika me nā protein plasma.
Inā nui ae ke ʻano nui, e ulu paha ka hypoglycemia.
Hoʻopili pū me nā lāʻau ʻē aʻe
Pono e noʻonoʻo pono i ka hui pū ʻana o ka lāʻau lapaʻau me nā anticoagulants, ʻoiai e hui pū ʻia, hiki nō ke hoʻonui i ka hopena o ka hopena o ka hopena.
Hoʻohui hui like ʻole
Hiki i ke Miconazole ke hōʻeha i ka comog hypoglycemic ke hoʻohana nei i ka gel ma ka mucosa waha a me ka hoʻokō hoʻonohonoho.
ʻAʻole i hāʻawi ʻia
E pili ana kēia:
- ʻO Phenylbutazone me ka ʻōnaehana hoʻoponopono ma muli o ka hopena hypoglycemic hopena. ʻOi aku ka maikaʻi e hoʻohana i kekahi lāʻau lapaʻau ʻē aʻe i ka mumū.
- ʻO Ethanol, kahi e hoʻonui ai i ka hypoglycemia a hiki i ke kūkulu houʻana o ka coma. ʻAʻole pono ke kina ʻana mai ka waiʻona wale nō, akā mai nā lāʻau lapaʻau hoʻi i loaʻa i kēia mea.
- Danazole - kōkua i ka hoʻonui ʻana i ke kao o ka glucose i ke koko.
Danazole - kōkua i ka hoʻonui ʻana i ke kao o ka glucose i ke koko.
ʻO nā hui e koi ana i ka mālama
Hoʻopili pū kekahi me ka lāʻau lapaʻau me kekahi mau lāʻau lapaʻau. E hoʻonui i ka hōʻeha o ka hypoglycemia:
- beta-blockers;
- nā mea hana'ē aʻe hypoglycemic: Insulin, Acarbose, GLP-1 agonists, thiazolidinidione, Metformin, dipeptidyl peptidase-4 inhibitors;
- Fluconazole;
- Nā MAO a me ACE inhibitors;
- histamine H2 blocker blockers;
- sulfonamides;
- Nā NSAID
- ʻO Clarithromycin
E hoʻonui i nā glucose koko:
- ʻO Chlorpromazine ma nā kala kiʻekiʻe;
- glucocorticosteroids;
- Terbutaline, Salbutamol, Ritodrin me ka hoʻokō intravenous.
ʻO Maninil kahi hoʻohālike o ka lāʻau lapaʻau Diabeton MV.
Nā hiʻina o ka Diabeton MV
E pili ana kēia:
- Maninil;
- Gliclazide MV;
- ʻO Glidiab;
- Huhu;
- Kau Kau inoa Diabefarm.
Hoʻohana ʻia nā mea kākau ma hope o ka nīnau ʻana i kahi kauka.
ʻO wai ka mea maikaʻi: Ka maʻi Diabeton a i ʻole Diabeton MV?
ʻOkoʻa nā maʻi Diabeton MV ma ka maʻi Diabeton o ka hoʻokuʻu ʻana o ka mea hana. "MV" kahi hoʻokuʻu i hoʻololi ʻia.
ʻO ka manawa o ka ea glycoside ma Diabeton ʻaʻoleʻoi aku ma mua o 2-3 mau hola. Dosis - 80 mg.
Lawe ʻia ka CF i hoʻokahi manawa i kēlā me kēia lā, hana pālahalaha ʻia, liʻiliʻi ka hopena o ka hypoglycemia.
ʻOkoʻa nā maʻi Diabeton MV ma ka maʻi Diabeton o ka hoʻokuʻu ʻana o ka mea hana.
Waihue huaʻōlelo waiho nā huaʻōlelo
ʻO ka lāʻau lapaʻau (Diabeton MR ma Latin) he lāʻau lapaʻau.
Uku helu no ka Diabeton MV
ʻO ka kumu kumukūʻai he 350 rubles.
Ke waiho nei i nā kūlana no ka lāʻau lapaʻau
I kahi wahi hiki ʻole i nā keiki, ma ke ʻano wela loa ʻaʻole + 25 ° C.
ʻO ka lā kau
2 makahiki
Mea hana
- "Laboratories Servier Industry", Farani.
- Serdix LLC, Rusia.
Hōʻikeʻike e pili ana i ka Diabeton MV
Kauka
Shishkina E.I., Moscow
He kiʻekiʻe ke koʻikoʻi. ʻAʻole ʻike ʻia nā hopena kūpono. Hoʻomaka koke ia i ka hana. ʻO ka lāʻau maikaʻi no ka maʻi maʻi maʻi.
Na maʻi maʻi maʻi maʻi
Diana, 55 makahiki, Samara
Ua kuhikuhi ke kauka i ke ʻano he 60 ml / lā, akā i kakahiaka aʻe ka hōʻila o ka glucose i ka 10-13. Me ka hoʻonuiʻana o ka dosage i 1.5 papa, ua emi ke pae o ke kakahiaka i 6 mm. Kōkua ka lāʻau liʻiliʻi kino me ke ʻai kōkua
